Macrophages in vascular inflammation – From atherosclerosis to vasculitis

References

• Mills, C. D. 2012. M1 and M2 macrophages: oracles of health and disease. Crit. Rev. Immunol. 32: 463–488
   PubMed Web of Science ®Google Scholar
• Gordon, S. 2002. Pattern recognition receptors: doubling up for the innate immune response. Cell 111: 927–930
   PubMed Web of Science ®Google Scholar
• Hansson, G. K., and A. Hermansson. 2011. The immune system in atherosclerosis. Nat. Immunol. 12: 204–212
   PubMed Web of Science ®Google Scholar
• Geissmann, F., M. G. Manz, S. Jung, et al. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656–661
   PubMed Web of Science ®Google Scholar
• Hoeffel, G., Y. Wang, M. Greter, et al. 2012. Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J. Exp. Med. 209: 1167–1181
   PubMedGoogle Scholar
• Dutta, P., G. Courties, Y. Wei, et al. 2012. Myocardial infarction accelerates atherosclerosis. Nature 487: 325–329
   PubMed Web of Science ®Google Scholar
• Moore, K. J., F. J. Sheedy, and E. A. Fisher. 2013. Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13: 709–721
   PubMed Web of Science ®Google Scholar
• Ley, K., C. Laudanna, M. I. Cybulsky, and S. Nourshargh. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7: 678–689
   PubMed Web of Science ®Google Scholar
• Li, A. C., and C. K. Glass. 2002. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 8: 1235–1242
   PubMed Web of Science ®Google Scholar
• Maiellaro, K., and W. R. Taylor. 2007. The role of the adventitia in vascular inflammation. Cardiovasc. Res. 75: 640–648
   PubMed Web of Science ®Google Scholar
• Fenyo, I. M., and A. V. Gafencu. 2013. The involvement of the monocytes/macrophages in chronic inflammation associated with atherosclerosis. Immunobiology 218: 1376–1384
   PubMed Web of Science ®Google Scholar
• Weber, C., and H. Noels. 2011. Atherosclerosis: current pathogenesis and therapeutic options. Nat. Med. 17: 1410–1422
   PubMed Web of Science ®Google Scholar
• Tacke, F., D. Alvarez, T. J. Kaplan, et al. 2007. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117: 185–194
   PubMed Web of Science ®Google Scholar
• Combadiere, C., S. Potteaux, M. Rodero, et al. 2008. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117: 1649–1657
   PubMed Web of Science ®Google Scholar
• Bush, E., N. Maeda, W. A. Kuziel, et al. 2000. CC chemokine receptor 2 is required for macrophage infiltration and vascular hypertrophy in angiotensin II-induced hypertension. Hypertension 36: 360–363
   PubMed Web of Science ®Google Scholar
• Mantovani, A., A. Sica, S. Sozzani, et al. 2004. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25: 677–686
   PubMed Web of Science ®Google Scholar
• Duong, C. Q., S. M. Bared, A. Abu-Khader, et al. 2004. Expression of the lysophospholipid receptor family and investigation of lysophospholipid-mediated responses in human macrophages. Biochim. Biophys. Acta 1682: 112–119
   PubMed Web of Science ®Google Scholar
• Michaud, J., D. S. Im, and T. Hla. 2010. Inhibitory role of sphingosine 1-phosphate receptor 2 in macrophage recruitment during inflammation. J. Immunol. 184: 1475–1483
   Google Scholar
• Keul, P., S. Lucke, K. von Wnuck Lipinski, et al. 2011. Sphingosine-1-phosphate receptor 3 promotes recruitment of monocyte/macrophages in inflammation and atherosclerosis. Circ. Res. 108: 314–323
   PubMed Web of Science ®Google Scholar
• Stenmark, K. R., M. E. Yeager, K. C. El Kasmi, et al. 2013. The adventitia: essential regulator of vascular wall structure and function. Annu. Rev. Physiol. 75: 23–47
   Web of Science ®Google Scholar
• Langheinrich, A. C., M. Kampschulte, T. Buch, and R. M. Bohle. 2007. Vasa vasorum and atherosclerosis - Quid novi? Thromb. Haemost. 97: 873–879
   Google Scholar
• Moulton, K. S., K. Vakili, D. Zurakowski, et al. 2003. Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. USA 100: 4736–4741
   PubMed Web of Science ®Google Scholar
• Gossl, M., D. Versari, D. Mannheim, et al. 2007. Increased spatial vasa vasorum density in the proximal LAD in hypercholesterolemia–implications for vulnerable plaque-development. Atherosclerosis 192: 246–252
   PubMed Web of Science ®Google Scholar
• Galkina, E., A. Kadl, J. Sanders, et al. 2006. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203: 1273–1282
   PubMed Web of Science ®Google Scholar
• Herrmann, J., L. O. Lerman, M. Rodriguez-Porcel, et al. 2001. Coronary vasa vasorum neovascularization precedes epicardial endothelial dysfunction in experimental hypercholesterolemia. Cardiovasc. Res. 51: 762–766
   PubMed Web of Science ®Google Scholar
• Trott, D. W., and D. G. Harrison. 2014. The immune system in hypertension. Adv. Physiol. Educ. 38: 20–24
   PubMed Web of Science ®Google Scholar
• Weyand, C. M., and J. J. Goronzy. 2013. Immune mechanisms in medium and large-vessel vasculitis. Nat. Rev. Rheumatol. 9: 731–740
   PubMed Web of Science ®Google Scholar
• Weyand, C. M., A. D. Wagner, J. Bjornsson, and J. J. Goronzy. 1996. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J. Clin. Invest. 98: 1642–1649
   PubMed Web of Science ®Google Scholar
• Pryshchep, O., W. Ma-Krupa, B. R. Younge, et al. 2008. Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 118: 1276–1284
   PubMed Web of Science ®Google Scholar
• Weyand, C. M., Y. J. Liao, and J. J. Goronzy. 2012. The immunopathology of giant cell arteritis: diagnostic and therapeutic implications. J. Neuroophthalmol. 32: 259–265
   PubMed Web of Science ®Google Scholar
• Ma-Krupa, W., M. Kwan, J. J. Goronzy, and C. M. Weyand. 2005. Toll-like receptors in giant cell arteritis. Clin. Immunol. 115: 38–46
   PubMed Web of Science ®Google Scholar
• Ma-Krupa, W., M. S. Jeon, S. Spoerl, et al. 2004. Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J. Exp. Med. 199: 173–183
   PubMed Web of Science ®Google Scholar
• Trogan, E., J. E. Feig, S. Dogan, et al. 2006. Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc. Natl. Acad. Sci. USA 103: 3781–3786
   PubMed Web of Science ®Google Scholar
• Mantovani, A., C. Garlanda, and M. Locati. 2009. Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler. Thromb. Vasc. Biol. 29: 1419–1423
   PubMed Web of Science ®Google Scholar
• Martinez, F. O., A. Sica, A. Mantovani, and M. Locati. 2008. Macrophage activation and polarization. Front. Biosci. 13: 453–461
   PubMed Web of Science ®Google Scholar
• Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958–969
   PubMed Web of Science ®Google Scholar
• Cohen, H. B., and D. M. Mosser. 2013. Extrinsic and intrinsic control of macrophage inflammatory responses. J. Leukoc. Biol. 94: 913–919
   PubMed Web of Science ®Google Scholar
• Martinez, F. O., and S. Gordon. 2014. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 6: 13
   PubMedGoogle Scholar
• Murray, P. J., J. E. Allen, S. K. Biswas, et al. 2014. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41: 14–20
   PubMed Web of Science ®Google Scholar
• Sica, A., and A. Mantovani. 2012. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Invest. 122: 787–795
   PubMed Web of Science ®Google Scholar
• Sica, A., and V. Bronte. 2007. Altered macrophage differentiation and immune dysfunction in tumor development. J. Clin. Invest. 117: 1155–1166
   PubMed Web of Science ®Google Scholar
• Krausgruber, T., K. Blazek, T. Smallie, et al. 2011. IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat. Immunol. 12: 231–238
   PubMed Web of Science ®Google Scholar
• Liao, X., N. Sharma, F. Kapadia, et al. 2011. Kruppel-like factor 4 regulates macrophage polarization. J. Clin. Invest. 121: 2736–2749
   PubMed Web of Science ®Google Scholar
• Cao, Z., X. Sun, B. Icli, et al. 2010. Role of Kruppel-like factors in leukocyte development, function, and disease. Blood 116: 4404–4414
   PubMed Web of Science ®Google Scholar
• Odegaard, J. I., R. R. Ricardo-Gonzalez, A. Red Eagle, et al. 2008. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab. 7: 496–507
   PubMed Web of Science ®Google Scholar
• Kang, K., S. M. Reilly, V. Karabacak, et al. 2008. Adipocyte-derived Th2 cytokines and myeloid PPARdelta regulate macrophage polarization and insulin sensitivity. Cell Metab. 7: 485–495
   PubMed Web of Science ®Google Scholar
• Odegaard, J. I., R. R. Ricardo-Gonzalez, M. H. Goforth, et al. 2007. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature 447: 1116–1120
   PubMed Web of Science ®Google Scholar
• Pauleau, A. L., R. Rutschman, R. Lang, et al. 2004. Enhancer-mediated control of macrophage-specific arginase I expression. J. Immunol. 172: 7565–7573
   PubMed Web of Science ®Google Scholar
• Whyte, C. S., E. T. Bishop, D. Ruckerl, et al. 2011. Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function. J. Leukoc. Biol. 90: 845–854
   PubMed Web of Science ®Google Scholar
• Date, D., R. Das, G. Narla, et al. 2014. Kruppel-like transcription factor 6 regulates inflammatory macrophage polarization. J. Biol. Chem. 289: 10318–10329
   PubMed Web of Science ®Google Scholar
• Mahabeleshwar, G. H., D. Kawanami, N. Sharma, et al. 2011. The myeloid transcription factor KLF2 regulates the host response to polymicrobial infection and endotoxic shock. Immunity 34: 715–728
   PubMed Web of Science ®Google Scholar
• Lawrence, T., and D. W. Gilroy. 2007. Chronic inflammation: a failure of resolution? Int. J. Exp. Pathol. 88: 85–94
   PubMed Web of Science ®Google Scholar
• Galkina, E., and K. Ley. 2009. Immune and inflammatory mechanisms of atherosclerosis. Annu. Rev. Immunol. 27: 165–197
   PubMed Web of Science ®Google Scholar
• Khallou-Laschet, J., A. Varthaman, G. Fornasa, et al. 2010. Macrophage plasticity in experimental atherosclerosis. PLoS One 5: e8852
   PubMed Web of Science ®Google Scholar
• Stoger, J. L., M. J. Gijbels, S. van der Velden, et al. 2012. Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225: 461–468
   PubMed Web of Science ®Google Scholar
• Butcher, M. J., and E. V. Galkina. 2012. Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta. Front. Physiol. 3: 44
   PubMed Web of Science ®Google Scholar
• Moore, K. J., and I. Tabas. 2011. Macrophages in the pathogenesis of atherosclerosis. Cell 145: 341–355
   PubMed Web of Science ®Google Scholar
• Weyand, C. M., and J. J. Goronzy. 2014. Clinical practice. Giant-cell arteritis and polymyalgia rheumatica. N. Engl. J. Med. 371: 50–57
   PubMed Web of Science ®Google Scholar
• Abd, T. T., D. J. Eapen, A. Bajpai, et al. 2011. The role of C-reactive protein as a risk predictor of coronary atherosclerosis: implications from the JUPITER trial. Curr. Atheroscler. Rep. 13: 154–161
   PubMed Web of Science ®Google Scholar
• Ciccia, F., R. Alessandro, A. Rizzo, et al. 2013. IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis. Ann. Rheum. Dis. 72: 258–264
   PubMed Web of Science ®Google Scholar
• Wagner, A. D., J. Bjornsson, G. B. Bartley, et al. 1996. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am. J. Pathol. 148: 1925–1933
   PubMed Web of Science ®Google Scholar
• El Kasmi, K. C., S. C. Pugliese, S. R. Riddle, et al. 2014. Adventitial fibroblasts induce a distinct proinflammatory/profibrotic macrophage phenotype in pulmonary hypertension. J. Immunol. 193: 97–609
   Google Scholar
• Rateri, D. L., D. A. Howatt, J. J. Moorleghen, et al. 2011. Prolonged infusion of angiotensin II in apoE(−/−) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. Am. J. Pathol. 179: 1542–1548
   PubMed Web of Science ®Google Scholar
• Ohlsson, S. M., C. P. Linge, B. Gullstrand, et al. 2014. Serum from patients with systemic vasculitis induces alternatively activated macrophage M2c polarization. Clin. Immunol. 152: 10–19
   PubMed Web of Science ®Google Scholar
• Miller, Y. I., S. H. Choi, P. Wiesner, et al. 2011. Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ. Res. 108: 235–248
   PubMed Web of Science ®Google Scholar
• Jennette, J. C., R. J. Falk, P. Hu, and H. Xiao. 2013. Pathogenesis of antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis. Annu. Rev. Pathol. 8: 139–160
   PubMedGoogle Scholar
• Hans, C. P., S. N. Koenig, N. Huang, et al. 2012. Inhibition of Notch1 signaling reduces abdominal aortic aneurysm in mice by attenuating macrophage-mediated inflammation. Arterioscler. Thromb. Vasc. Biol. 32: 3012–3023
   Google Scholar
• Takahashi, K., T. Oharaseki, and Y. Yokouchi. 2011. Pathogenesis of Kawasaki disease. Clin. Exp. Immunol. 164 Suppl 1: 20–22
   Google Scholar
• Arnaud, L., J. Haroche, A. Mathian, et al. 2011. Pathogenesis of Takayasu's arteritis: a 2011 update. Autoimmun. Rev. 11: 61–67
   PubMed Web of Science ®Google Scholar
• Ait-Oufella, H., S. Taleb, Z. Mallat, and A. Tedgui. 2011. Recent advances on the role of cytokines in atherosclerosis. Arterioscler. Thromb. 31: 969–979
   PubMed Web of Science ®Google Scholar
• Stoneman, V. E., and M. R. Bennett. 2009. Role of Fas/Fas-L in vascular cell apoptosis. J. Cardiovasc. Pharmacol. 53: 100–108
   Google Scholar
• Barks, J. L., J. J. McQuillan, and M. F. Iademarco. 1997. TNF-alpha and IL-4 synergistically increase vascular cell adhesion molecule-1 expression in cultured vascular smooth muscle cells. J. Immunol. 159: 4532–4538
   Web of Science ®Google Scholar
• Wang, S. C., S. B. Kanner, J. A. Ledbetter, et al. 1995. Evidence for LFA-1/ICAM-1 dependent stimulation of protein tyrosine phosphorylation in human B lymphoid cell lines during homotypic adhesion. J. Leukoc. Biol. 57: 343–351
   Google Scholar
• Simionescu, M. 2009. Cellular dysfunction in inflammatory-related vascular disorders' review series. The inflammatory process: a new dimension of a 19 century old story. J. Cell. Mol. Med. 13: 4291–4292
   Google Scholar
• Esmon, C. T. 2004. The impact of the inflammatory response on coagulation. Thromb. Res. 114: 321–327
   PubMed Web of Science ®Google Scholar
• Kruithof, E. K. 2008. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb. Haemost. 100: 969–975
   PubMed Web of Science ®Google Scholar
• Mallat, Z., A. Gojova, C. Marchiol-Fournigault, et al. 2001. Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice. Circ. Res. 89: 930–934
   PubMed Web of Science ®Google Scholar
• Bode, J. G., C. Ehlting, and D. Haussinger. 2012. The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. Cell. Signal. 24: 1185–1194
   PubMed Web of Science ®Google Scholar
• Colonnello, J. S., K. A. Hance, M. L. Shames, et al. 2003. Transient exposure to elastase induces mouse aortic wall smooth muscle cell production of MCP-1 and RANTES during development of experimental aortic aneurysm. J. Vasc. Surg. 38: 138–146
   Google Scholar
• Gerszten, R. E., E. A. Garcia-Zepeda, Y. C. Lim, et al. 1999. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 398: 718–723
   PubMed Web of Science ®Google Scholar
• Cheung, Y. F., K. O, S. C. Tam, and Y. L. Siow. 2005. Induction of MCP1, CCR2, and iNOS expression in THP-1 macrophages by serum of children late after Kawasaki disease. Pediatr. Res. 58: 1306–1310
   Google Scholar
• Nazari-Jahantigh, M., Y. Wei, H. Noels, et al. 2012. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J. Clin. Invest. 122: 4190–4202
   PubMed Web of Science ®Google Scholar
• Adema, G. J., F. Hartgers, R. Verstraten, et al. 1997. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature 387: 713–717
   PubMed Web of Science ®Google Scholar
• Newby, A. C. 2005. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol. Rev. 85: 1–31
   PubMed Web of Science ®Google Scholar
• Sakakura, K., M. Nakano, F. Otsuka, et al. 2013. Pathophysiology of atherosclerosis plaque progression. Heart Lung. Circ. 22: 399–411
   PubMed Web of Science ®Google Scholar
• Yan, Z. Q., and G. K. Hansson. 2007. Innate immunity, macrophage activation, and atherosclerosis. Immunol. Rev. 219: 187–203
   PubMed Web of Science ®Google Scholar
• Daugherty, A., and L. A. Cassis. 2004. Mouse models of abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 24: 429–434
   PubMed Web of Science ®Google Scholar
• Burns, J. C., and M. P. Glode. 2004. Kawasaki syndrome. Lancet 364: 533–544
   PubMed Web of Science ®Google Scholar
• Weyand, C. M., and J. J. Goronzy. 2003. Medium- and large-vessel vasculitis. N. Engl. J. Med. 349: 160–169
   PubMed Web of Science ®Google Scholar
• Kaiser, M., B. Younge, J. Bjornsson, et al. 1999. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells. Am. J. Pathol. 155: 765–774
   PubMed Web of Science ®Google Scholar
• Kaiser, M., C. M. Weyand, J. Bjornsson, and J. J. Goronzy. 1998. Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis. Arthritis Rheum. 41: 623–633
   PubMed Web of Science ®Google Scholar
• Manea, A., and M. Simionescu. 2012. Nox enzymes and oxidative stress in atherosclerosis. Front. Biosci. (Schol Ed). 4: 651–670
   PubMedGoogle Scholar
• Rittner, H. L., M. Kaiser, A. Brack, et al. 1999. Tissue-destructive macrophages in giant cell arteritis. Circ. Res. 84: 1050–1058
   PubMed Web of Science ®Google Scholar
• Rittner, H. L., V. Hafner, P. A. Klimiuk, et al. 1999. Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J. Clin. Invest. 103: 1007–1013
   PubMed Web of Science ®Google Scholar
• Tavakoli, S., and R. Asmis. 2012. Reactive oxygen species and thiol redox signaling in the macrophage biology of atherosclerosis. Antioxid. Redox. Signal. 17: 1785–1795
   Google Scholar
• Qiao, M., Q. Zhao, C. F. Lee, et al. 2009. Thiol oxidative stress induced by metabolic disorders amplifies macrophage chemotactic responses and accelerates atherogenesis and kidney injury in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 29: 1779–1786
   Google Scholar
• McPhillips, K., W. J. Janssen, M. Ghosh, et al. 2007. TNF-alpha inhibits macrophage clearance of apoptotic cells via cytosolic phospholipase A2 and oxidant-dependent mechanisms. J. Immunol. 178: 8117–8126
   PubMed Web of Science ®Google Scholar
• Steinberg, D., and J. L. Witztum. 2002. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis? Circulation 105: 2107–2111
   PubMed Web of Science ®Google Scholar
• Tian, W., X. Jiang, R. Tamosiuniene, Y. K. Sung, et al. 2013. Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension. Sci. Transl. Med. 5: 200ra117
   PubMed Web of Science ®Google Scholar
• Andres, V., O. M. Pello, and C. Silvestre-Roig. 2012. Macrophage proliferation and apoptosis in atherosclerosis. Curr. Opin. Lipidol. 23: 429–438
   PubMed Web of Science ®Google Scholar
• Seimon, T. A., M. J. Nadolski, X. Liao, et al. 2010. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell. Metab. 12: 467–482
   PubMed Web of Science ®Google Scholar
• Tabas, I. 2007. Apoptosis and efferocytosis in mouse models of atherosclerosis. Curr. Drug Targets 8: 1288–1296
   PubMed Web of Science ®Google Scholar
• Tabas, I. 2005. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 25: 2255–2264
   PubMed Web of Science ®Google Scholar
• Clarke, M. C., N. Figg, J. J. Maguire, et al. 2006. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat. Med. 12: 1075–1080
   PubMed Web of Science ®Google Scholar
• Imanishi, T., D. K. Han, L. Hofstra, et al. 2002. Apoptosis of vascular smooth muscle cells is induced by Fas ligand derived from monocytes/macrophage. Atherosclerosis 161: 143–151
   Google Scholar
• Seshiah, P. N., D. J. Kereiakes, S. S. Vasudevan, et al. 2002. Activated monocytes induce smooth muscle cell death: role of macrophage colony-stimulating factor and cell contact. Circulation 105: 174–180
   Google Scholar
• Yao, P. M., and I. Tabas. 2000. Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J. Biol. Chem. 275: 23807–23813
   Google Scholar
• Tabas, I. 2009. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid. Redox. Signal. 11: 2333–2339
   PubMed Web of Science ®Google Scholar
• Schrijvers, D. M., G. R. De Meyer, A. G. Herman, and W. Martinet. 2007. Phagocytosis in atherosclerosis: molecular mechanisms and implications for plaque progression and stability. Cardiovasc. Res. 73: 470–480
   PubMed Web of Science ®Google Scholar
• Maderna, P., and C. Godson. 2003. Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim. Biophys. Acta 1639: 141–151
   PubMed Web of Science ®Google Scholar
• Harper, L., P. Cockwell, D. Adu, and C. O. Savage. 2001. Neutrophil priming and apoptosis in anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Kidney Int. 59: 1729–1738
   PubMed Web of Science ®Google Scholar
• van Rossum, A. P., F. Fazzini, P. C. Limburg, et al. 2004. The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages. Arthritis Rheum. 50: 2667–2674
   PubMedGoogle Scholar
• Gabillet, J., A. Millet, M. Pederzoli-Ribeil, et al. 2012. Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation. J. Immunol. 189: 2574–2583
   PubMedGoogle Scholar
• Witztum, J. L., and A. H. Lichtman. 2014. The influence of innate and adaptive immune responses on atherosclerosis. Annu. Rev. Pathol. 9: 73–102
   PubMed Web of Science ®Google Scholar
• Helming, L., and S. Gordon. 2009. Molecular mediators of macrophage fusion. Trends Cell. Biol. 19: 514–522
   PubMed Web of Science ®Google Scholar
• Wynn, T. A., A. Chawla, and J. W. Pollard. 2013. Macrophage biology in development, homeostasis and disease. Nature 496: 445–455
   PubMed Web of Science ®Google Scholar
• Smith, E., K. M. Prasad, M. Butcher, et al. 2010. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation 121: 1746–1755
   PubMed Web of Science ®Google Scholar
• Gan, P. Y., O. M. Steinmetz, D. S. Tan, et al. 2010. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J. Am. Soc. Nephrol. 21: 925–931
   PubMed Web of Science ®Google Scholar
• Schulte, D. J., A. Yilmaz, K. Shimada, et al. 2009. Involvement of innate and adaptive immunity in a murine model of coronary arteritis mimicking Kawasaki disease. J. Immunol. 183: 5311–5318
   PubMed Web of Science ®Google Scholar
• Lee, T., J. W. Seo, B. E. Sumpio, and S. J. Kim. 2003. Immunobiologic analysis of arterial tissue in Buerger's disease. Eur. J. Vasc. Endovasc. Surg. 25: 451–457
   PubMed Web of Science ®Google Scholar
• Kobayashi, M., M. Ito, A. Nakagawa, et al. 1999. Immunohistochemical analysis of arterial wall cellular infiltration in Buerger's disease (endarteritis obliterans). J. Vasc. Surg. 29: 451–458
   Google Scholar
• Huang, X. R., P. G. Tipping, J. Apostolopoulos, et al. 1997. Mechanisms of T cell-induced glomerular injury in anti-glomerular basement membrane (GBM) glomerulonephritis in rats. Clin. Exp. Immunol. 109: 134–142
   PubMed Web of Science ®Google Scholar
• Sheikh-Hamad, D. 2010. Mammalian stanniocalcin-1 activates mitochondrial antioxidant pathways: new paradigms for regulation of macrophages and endothelium. Am. J. Physiol. Renal. Physiol. 298: F248–F254
   PubMedGoogle Scholar
• Duffield, J. S., P. G. Tipping, T. Kipari, et al. 2005. Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am. J. Pathol. 167: 1207–1219
   Google Scholar
• Tahara, N., J. Mukherjee, H. J. de Haas, et al. 2014. 2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis. Nat. Med. 20: 215–219
   Google Scholar
• Blockmans, D. 2011. PET in vasculitis. Ann. N. Y. Acad. Sci. 1228: 64–70
   PubMed Web of Science ®Google Scholar
• O'Neill, L. A., and D. G. Hardie. 2013. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493: 346–355
   PubMed Web of Science ®Google Scholar
• Jezovnik, M. K., N. Zidar, L. Lezaic, et al. 2014. Identification of inflamed atherosclerotic lesions in vivo using PET-CT. Inflammation 37: 426–434
   Google Scholar
• Tawakol, A., R. Q. Migrino, G. G. Bashian, et al. 2006. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J. Am. Coll. Cardiol. 48: 1818–1824
   PubMed Web of Science ®Google Scholar
• Sigovan, M., A. Bessaad, H. Alsaid, et al. 2010. Assessment of age modulated vascular inflammation in ApoE−/− mice by USPIO-enhanced magnetic resonance imaging. Invest. Radiol. 45: 702–707
   Google Scholar
• Kooi, M. E., V. C. Cappendijk, K. B. Cleutjens, et al. 2003. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107: 2453–2458
   PubMed Web of Science ®Google Scholar
• Osborn, E. A., and F. A. Jaffer. 2013. The advancing clinical impact of molecular imaging in CVD. JACC Cardiovasc. Imaging 6: 1327–1341
   PubMed Web of Science ®Google Scholar
• Croons, V., W. Martinet, and G. R. De Meyer. 2010. Selective removal of macrophages in atherosclerotic plaques as a pharmacological approach for plaque stabilization: benefits versus potential complications. Curr. Vasc. Pharmacol. 8: 495–508
   Google Scholar
• Calin, M. V., I. Manduteanu, E. Dragomir, et al. 2009. Effect of depletion of monocytes/macrophages on early aortic valve lesion in experimental hyperlipidemia. Cell. Tissue Res. 336: 237–248
   Google Scholar
• Schulz, C., and S. Massberg. 2014. Atherosclerosis-multiple pathways to lesional macrophages. Sci. Transl. Med. 6: 239ps232
   Google Scholar
• Tardif, J. C., J. J. McMurray, E. Klug, et al. 2008. Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial. Lancet 371: 1761–1768
   PubMed Web of Science ®Google Scholar
• Yuan, F., D. E. Tabor, R. K. Nelson, et al. 2013. A dexamethasone prodrug reduces the renal macrophage response and provides enhanced resolution of established murine lupus nephritis. PLoS One 8: e81483
   Google Scholar
• Missiou, A., N. Kostlin, N. Varo, et al. 2010. Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall. Circulation 121: 2033–2044
   Google Scholar
• Kirsch, T., A. Woywodt, J. Klose, et al. 2010. Endothelial-derived thrombospondin-1 promotes macrophage recruitment and apoptotic cell clearance. J. Cell. Mol. Med. 14: 1922–1934
   Google Scholar
• Jenkins, S. J., D. Ruckerl, G. D. Thomas, et al. 2013. IL-4 directly signals tissue-resident macrophages to proliferate beyond homeostatic levels controlled by CSF-1. J. Exp. Med. 210: 2477–2491
   PubMed Web of Science ®Google Scholar
• Ridker, P. M., T. Thuren, A. Zalewski, and P. Libby. 2011. Interleukin-1beta inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am. Heart J. 162: 597–605
   PubMed Web of Science ®Google Scholar
• Callegari, A., Y. Liu, C. C. White, et al. 2011. Gain and loss of function for glutathione synthesis: impact on advanced atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 31: 2473–2482
   Google Scholar
• Rayner, K. J., F. J. Sheedy, C. C. Esau, et al. 2011. Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J. Clin. Invest. 121: 2921–2931
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet, L., C. Welch, T. A. Pagler, et al. 2008. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118: 1837–1847
   PubMed Web of Science ®Google Scholar
• Piggott, K., J. Deng, K. Warrington, et al. 2011. Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis. Circulation 123: 309–318
   Google Scholar
• Pan, H., J. W. Myerson, L. Hu, et al. 2013. Programmable nanoparticle functionalization for in vivo targeting. FASEB J. 27:255–264
   PubMed Web of Science ®Google Scholar
• Leuschner, F., P. Dutta, R. Gorbatov, et al. 2011. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol. 29: 1005–1010
   PubMed Web of Science ®Google Scholar
• Spears, L. D., B. Razani, and C. F. Semenkovich. 2013. Interleukins and atherosclerosis: a dysfunctional family grows. Cell. Metab. 18: 614–616
   Google Scholar
• Singh, M. V., M. W. Chapleau, S. C. Harwani, and F. M. Abboud. 2014. The immune system and hypertension. Immunol. Res. 59: 243–253
   PubMed Web of Science ®Google Scholar
• Mihm, B., M. Bergmann, W. Bruck, and S. Probst-Cousin. 2013. The activation pattern of macrophages in giant cell (temporal) arteritis and primary angiitis of the central nervous system. Neuropathology 34: 236–242
   Google Scholar
• Wang, H., L. Li, L. Wang, et al. 2012. Comparison of clinical and pathological characteristics of isolated aortitis and Takayasu arteritis with ascending aorta involvement. J. Clin. Pathol. 65: 362–366
   Google Scholar
• Han, Y., F. Y. Ma, G. H. Tesch, et al. 2011. c-fms blockade reverses glomerular macrophage infiltration and halts development of crescentic anti-GBM glomerulonephritis in the rat. Lab. Invest. 91: 978–991
   PubMed Web of Science ®Google Scholar
• Rastaldi, M. P., F. Ferrario, A. Crippa, et al. 2000. Glomerular monocyte-macrophage features in ANCA-positive renal vasculitis and cryoglobulinemic nephritis. J. Am. Soc. Nephrol. 11: 2036–2043
   Google Scholar
• Ketha, S. S., and L. T. Cooper. 2013. The role of autoimmunity in thromboangiitis obliterans (Buerger's disease). Ann. N. Y. Acad. Sci. 1285: 15–25
   Google Scholar